bpc-157 clinical trials human safety review Peptide Therapy for Pain Management and Healing BPC-157: What the Science Says

One paper ( via the VEGF/ERK signaling pathway after traumatic brain injury, implying that it might improve prognosis following HIBD by promoting endogenous neurogenesis

Preferred injection sites are the abdomen (away from the navel), upper thighs, and upper arms

If symptoms like persistent fatigue, brain fog, tingling, or balance issues continue without a clear explanation, it is worth initiating a deeper conversation with your provider

Different pharmacokinetics, different exposure profile A subcutaneous injection creates a systemic exposure profile fundamentally different from a topical application

They've done research on this